CEO and Chief Scientific Officer

Dr. Eugene Roussel,  Ph.D. Immunology  M.S. Immunology, B.S. Microbiology 

Dr. Roussel is cofounder of IMUNAR and has been in the biobusiness industry for 14 years.  He is a scientific expert with 25 years of career as an immunologist, studying immunology and inflammation with specialization in tumor immunology in four cancer centers across North America including MD Anderson Cancer Center, Houston, TX.   Dr. Roussel has spoken in many international conferences.  He has received 3 international scientific awards and he has authored over 20 international publications in the fields of tumor immunology, inflammation and proteomics.  He holds four patents in biotherapy of solid tumors with additional ones pending.

 

 


CFO

Mr. Carl Heeder, MS Industrial Administration, AB

Mr. Heeder has forty-one years of experience as Corporate Manager, Vice President and Chief Financial Officer.  He worked as a corporate officer for 10 different multinational  companies, including Norton Company, Artel Communications, State Street Bank & Trust Company, Bremer Vulkan AG, Westwood Associates, and ST Inverter America, Inc.  As a Westwood Associates, he worked as CFO for a pharmaceutical R&D firm.

 

 

 




COO

Dr. Marie-Claude Gingras, Ph.D. Biochemistry, B.S. Microbiology

Dr. Gingras is cofounder of IMUNAR and is a scientific expert in molecular biology, genetics, proteomics and cancer with twenty-five years of career and over thirty publications in international scientific journals.  Dr. Gingras is a Faculty at Baylor College of Medicine since 1994. She is laboratory director at the Baylor Human Genome Sequencing Center.